ilShinbiobase Co., Ltd.

ilShinbiobase Co., Ltd.

KKRX:068330
982.00
KRW
+1.00
(+0.10%)
122.51EPS
11.44P/E
58.39BMarket Cap
ilShinbiobase Co., Ltd.
KRX:068330
(Korea Stock Exchange)

Recent

price

982.00

P/E

ratio

11.44

div

yld

-NaN%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
330.15
231.08
318.01
44.86
291.52
307.74
307.69
292.76
350.4
458.07
436.78
570.19
476.68
390.32
258.26
348.61
363.82
Revenue per Share
50.08
21.02
39.4
4.6
44
61
62
48
72
108.54
93
137
89
148
91
115
122.51
Basic EPS, GAAP
-72.32
-83.18
27.93
-1.74
75.92
3.83
37.63
38.92
98.31
120.52
71.78
139.65
49.55
134.45
97.1
125.85
207.36
Free Cash Flow per Basic Share
4.97
5.45
- -
- -
- -
5.11
- -
- -
- -
5
6.23
7.02
7
7.13
6.96
7
- -
Dividend per Share
443.8
507.17
547.6
518.44
565
582.82
745.96
796.56
833.2
936.86
1,035.3
1,168.29
1,255.52
1,369.2
1,450.44
1,554.74
1,568.14
Book Value per Share
441.58
487.04
526.74
499.82
551.41
572.17
719.11
771.2
803.1
901.69
994.1
1,115.14
1,213.81
1,327.29
1,409.43
1,514.33
1,551.04
Tangible Book Value per Share
43
39
39
217
42
42
43
44
44
43
48
43
43
42
42
42
42
Basic Weighted Avg Shares
14,133
9,005
12,406
9,725
12,360
12,896
13,357
12,837
15,383
19,636
21,035
24,379
20,433
16,437
10,818
14,530
15,163
Sales/Revenue/Turnover
19.02
10.15
15.05
11.51
16.79
20.46
22.53
18.24
19.74
26.56
26.67
30.1
25.26
37.81
20.91
31.4
30.18
Operating Margin (%)
281
532
698
658
614
589
537
534
541
566
585
576
462
460
440
433
434
Depreciation Expense
2,144
819
1,537
997
1,866
2,556
2,691
2,105
3,161
4,653
4,479
5,858
3,815
6,232
3,812
4,793
5,106
Net Income, GAAP
20.95
13.79
17.18
10.4
15.66
14.38
17.62
16.42
23.23
16.96
25.98
25.06
18.9
19.63
17.64
18.27
18.43
Effective Tax Rate (%)
15.17
9.1
12.39
10.25
15.09
19.82
20.15
16.4
20.55
23.7
21.29
24.03
18.67
37.92
35.24
32.99
33.67
Profit Margin (%)
6,012
6,889
8,605
8,029
9,386
10,259
18,157
19,574
19,357
23,735
27,260
32,221
36,751
43,083
46,366
51,531
53,222
Working Capital
- -
3,000
3,000
1,200
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
19,023
19,763
21,381
22,287
24,297
24,273
32,949
34,892
34,940
39,480
44,379
50,080
53,819
57,064
60,450
64,796
65,355
Total Equity
11.67
3.99
6.61
4.19
7.32
9.19
8.44
5.75
6.84
11.92
10.09
11.48
7.83
8.93
3.17
5.94
5.91
Return on Invested Capital (%)
11.84
4.38
7.25
4.35
7.8
10.98
9.35
7.07
10.33
12.25
11.89
12.4
7.34
11.24
6.49
7.65
8.09
Return on Capital (%)
11.89
4.22
7.48
4.58
8.04
10.54
9.4
6.17
8.91
12.26
10.6
12.4
7.34
11.24
6.49
7.65
8.09
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
42
42
42
Market Capitalization
67,058
67,141
58,389

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
53,861
55,259
60,489
Cash, Cash Equivalents & STI
40,868
42,665
47,414
Accounts Receivable, Net
2,129
2,756
1,422
Inventories
9,952
9,170
10,428
Total Current Liabilities
3,732
3,729
7,267
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.67%
7.89%
7.19%
Free Cash Flow
123.77%
35.13%
28.97%
Net Income, GAAP
12.33%
9.24%
25.75%
Sales/Revenue/Turnover
3.46%
-3.94%
34.32%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,544
2,766
2,623
3,886
10,818
2025
1,886
3,543
4,868
4,234
14,530
2026
2,518
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
14
19
13
45.83
91
2025
16
17.81
46.15
35.15
115
2026
23.4
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
6.96
2025
- -
- -
- -
- -
7
2026
- -
- -
- -
- -
- -
Business
ilShinbiobase Co Ltd ilShinbiobase Co Ltd manufactures industrial refrigeration equipment for laboratory and biotechnology applications. The company produces ultra-low temperature deep freezers, freeze dryers, refrigerators, quick freezers, ice makers, shakers, blood bank refrigerators, incubators and ultra-pure water purification equipment; these products support research organizations, pharmaceutical firms, food companies and medical facilities by preserving reagents, microorganisms, strains and biological samples through rapid cooling systems and isolated cabinets. Founded in 1988 and headquartered in Dongducheon-si, Gyeonggi-do, South Korea, ilShinbiobase operates primarily in the biotechnology and laboratory equipment sector, exporting to over 50 countries including the United States, Europe, the Middle East, Australia, China and the Netherlands, with approximately 51 to 100 employees. The company listed on the Korea Exchange in December 2007 under ticker 068330.KS and holds certifications such as ISO9001 and CE mark. In recent developments, ilShinbiobase maintains its focus on research and development investments to enhance product quality and expand its global market presence, while introducing IoT-enabled remote monitoring features for real-time operational oversight via manufacturer servers and user smartphones.